Quantification of hepatitis B virus HBsAg: clinical implications

被引:5
作者
Buti, Maria [1 ,3 ]
Rodriguez Frias, Francisco [2 ,3 ]
Esteban, Rafael [1 ,3 ]
机构
[1] Hosp Univ Vall dHebron, Serv Hepatol, Barcelona, Spain
[2] Hosp Univ Vall dHebron, Serv Bioquim, Barcelona, Spain
[3] Inst Carlos III, CIBEREHD, Barcelona, Spain
来源
MEDICINA CLINICA | 2012年 / 138卷 / 11期
关键词
Hepatitis B; Antiviral therapy; HBsAg; SURFACE-ANTIGEN DECLINE; HBV DNA LEVELS; NATURAL-HISTORY; PEGINTERFERON ALPHA-2A; SUSTAINED RESPONSE; POSITIVE PATIENTS; VIRAL LOAD; HBEAG; PREDICTION; PROTEINS;
D O I
10.1016/j.medcli.2011.04.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The surface antigen of hepatitis B virus (HBsAg) is the main serological marker of HBV infection since its discovery almost 50 years ago. Currently the quantification of HBsAg has acquired special relevance as there are commercial tests to measure its levels. Several studies have shown that in patients treated with pegylated interferon alfa the fall of HBsAg levels predicts the loss of HBsAg and persistent virologic response. The role of the quantification of HBsAg in the treatment with nucleoside analogues is still not well understood and requires further studies. (C) 2011 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:483 / 488
页数:6
相关论文
共 31 条
[1]   Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration [J].
Bill, CA ;
Summers, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (30) :11135-11140
[2]   A NEW ANTIGEN IN LEUKEMIA SERA [J].
BLUMBERG, BS ;
ALTER, HJ ;
VISNICH, S .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1965, 191 (07) :541-&
[3]   Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers [J].
Brunetto, Maurizia Rossana ;
Oliveri, Filippo ;
Colombatto, Piero ;
Moriconi, Francesco ;
Ciccorossi, Pietro ;
Coco, Barbara ;
Romagnoli, Veronica ;
Cherubini, Beatrice ;
Moscato, Giovanna ;
Maina, Anna Maria ;
Cavallone, Daniela ;
Bonino, Ferruccio .
GASTROENTEROLOGY, 2010, 139 (02) :483-490
[4]   Hepatitis B Virus Surface Antigen Levels: A Guide to Sustained Response to peginterferon alfa-2a in HBeAg-Negative Chronic Hepatitis B [J].
Brunetto, Maurizia Rossana ;
Moriconi, Francesco ;
Bonino, Ferruccio ;
Lau, George K. K. ;
Farci, Patrizia ;
Yurdaydin, Cihan ;
Piratvisuth, Teerha ;
Luo, Kanxian ;
Wang, Yuming ;
Hadziyannis, Stephanos ;
Wolf, Eva ;
McCloud, Philip ;
Batrla, Richard ;
Marcellin, Patrick .
HEPATOLOGY, 2009, 49 (04) :1141-1150
[5]  
Buffello-Le Guillou D, 2000, J VIRAL HEPATITIS, V7, P387
[6]   Serum HBsAg changes in HBeAg positive chronic hepatitis B patients with continuous viral load reductions during treatment with adefovir or peg-interferon-α-2a [J].
Chen, Jinjun ;
Wang, Zhanhui ;
Guo, Yabing ;
Peng, Jie ;
Sun, Jian ;
Ahmed, Choudhary Shoaib ;
Zhou, Yuanping ;
Hou, Jinlin .
ANTIVIRAL RESEARCH, 2009, 81 (01) :88-91
[7]   THE S-PROMOTER OF HEPATITIS-B VIRUS IS REGULATED BY POSITIVE AND NEGATIVE ELEMENTS [J].
DEMEDINA, T ;
FAKTOR, O ;
SHAUL, Y .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (06) :2449-2455
[8]   HEPATIC EXPRESSION PATTERNS OF THE LARGE AND MIDDLE HEPATITIS-B VIRUS SURFACE-PROTEINS IN VIREMIC AND NONVIREMIC CHRONIC HEPATITIS-B [J].
DIENES, HP ;
GERLICH, WH ;
WORSDORFER, M ;
GERKEN, G ;
BIANCHI, L ;
HESS, G ;
ZUMBUSCHENFELDE, KHM .
GASTROENTEROLOGY, 1990, 98 (04) :1017-1023
[9]   HBSAG KINETICS OF DECAY AND BASELINE CHARACTERISTICS OF HBEAG-POSITIVE PATIENTS WITH CHRONIC HEPATITIS B FOLLOWING 3 YEARS OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT [J].
Gane, E. ;
Heathcote, E. J. ;
Marcellin, P. ;
Dusheiko, G. ;
Jacobson, I. ;
de Man, R. ;
Zeuzem, S. ;
Nikolaidis, P. ;
Sorbel, J. ;
Mondou, E. ;
Anderson, J. ;
Rousseau, F. .
JOURNAL OF HEPATOLOGY, 2010, 52 :S388-S388
[10]   LARGE SURFACE-PROTEINS OF HEPATITIS-B VIRUS CONTAINING THE PRE-S SEQUENCE [J].
HEERMANN, KH ;
GOLDMANN, U ;
SCHWARTZ, W ;
SEYFFARTH, T ;
BAUMGARTEN, H ;
GERLICH, WH .
JOURNAL OF VIROLOGY, 1984, 52 (02) :396-402